Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique

BACKGROUND: In late 2002, the health authorities of Mozambique implemented sulphadoxine-pyrimethamine (SP)/amodiaquine (AQ) as first-line treatment against uncomplicated falciparum malaria. In 2004, this has been altered to SP/artesunate in line with WHO recommendations of using Artemisinin Combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Enosse, Sonia, Magnussen, Pascal, Abacassamo, Fatima, Gómez-Olivé, Xavier, Rønn, Anita M, Thompson, Ricardo, Alifrangis, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481262/
https://www.ncbi.nlm.nih.gov/pubmed/18590577
http://dx.doi.org/10.1186/1475-2875-7-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481262/
https://www.ncbi.nlm.nih.gov/pubmed/18590577
http://dx.doi.org/10.1186/1475-2875-7-115

Ejemplares similares